Ranked #1
News From the San Antonio Breast Cancer Symposium
News From the San Antonio Breast Cancer Symposium
In this episode, we’ll cover three important presentations from the San Antonio Breast Cancer Symposium. The first repor... Read more
19 Dec 2019
•
12mins
Ranked #2
Benefit of Daratumumab Across Populations With Newly Diagnosed Multiple Myeloma
Benefit of Daratumumab Across Populations With Newly Diagnosed Multiple Myeloma
This week, we review a presentation on the benefit of daratumumab across populations with newly diagnosed multiple myelo... Read more
26 Sep 2019
•
16mins
Similar Podcasts
Ranked #3
ESMO World GI: Findings From the BEACON CRC Trial and More
ESMO World GI: Findings From the BEACON CRC Trial and More
We discuss two studies on colorectal cancer that were presented at the ESMO World Congress on Gastrointestinal Cancer. W... Read more
11 Jul 2019
•
10mins
Ranked #4
Sequence of Therapies for Metastatic Castration-Resistant Prostate Cancer
Sequence of Therapies for Metastatic Castration-Resistant Prostate Cancer
We’ll start with a trial focused on the sequence of therapies for metastatic, castration-resistant prostate cancer. Then... Read more
5 Dec 2019
•
11mins
Ranked #5
News in Genitourinary Cancers From ESMO 2019
News in Genitourinary Cancers From ESMO 2019
This week, we discuss two studies in genitourinary cancers presented at the ESMO Congress 2019. The CARD trial investiga... Read more
24 Oct 2019
•
17mins
Ranked #6
Gastrointestinal Cancer Research From ESMO 2019
Gastrointestinal Cancer Research From ESMO 2019
This week, we discuss two studies in gastrointestinal cancers presented at this year’s European Society for Medical Onco... Read more
31 Oct 2019
•
22mins
Ranked #7
Plenary Presentations From the 2019 ASH Annual Meeting & Exposition
Plenary Presentations From the 2019 ASH Annual Meeting & Exposition
On this episode, we hear from the authors of three high-impact abstracts presented at the 2019 ASH Annual Meeting & ... Read more
13 Dec 2019
•
12mins
Ranked #8
Lung Cancer Research Highlights From ESMO 2019
Lung Cancer Research Highlights From ESMO 2019
This week, we’ll be discussing research highlights in lung cancer presented at the ESMO Congress 2019, including the FLA... Read more
10 Oct 2019
•
19mins
Ranked #9
Ibrutinib and Rituximab vs Standard Chemoimmunotherapy in CLL
Ibrutinib and Rituximab vs Standard Chemoimmunotherapy in CLL
This week, we review a report on the combination of ibrutinib and rituximab vs standard chemoimmunotherapy in some patie... Read more
16 Aug 2019
•
17mins
Ranked #10
Pooled Survival Analysis of Patients With NSCLC Treated With Nivolumab
Pooled Survival Analysis of Patients With NSCLC Treated With Nivolumab
This week, we review a pooled analysis of long-term survival rates in patients with previously treated non–small cell lu... Read more
30 Aug 2019
•
17mins
Ranked #11
2019 ASCO: Resection of Liver Metastases
2019 ASCO: Resection of Liver Metastases
In this episode, we discuss more news from the ASCO Annual Meeting, including findings from a study with relevance to s... Read more
20 Jun 2019
•
15mins
Ranked #12
Nivolumab Plus Bevacizumab for Relapsed Ovarian Cancer
Nivolumab Plus Bevacizumab for Relapsed Ovarian Cancer
According to findings from a phase II trial, the combination of nivolumab and bevacizumab has shown activity in relapsed... Read more
22 Nov 2019
•
20mins
Ranked #13
News From the 2020 Multidisciplinary Head and Neck Cancers Symposium
News From the 2020 Multidisciplinary Head and Neck Cancers Symposium
This week, we’ll hear from two researchers on findings presented at the 2020 Multidisciplinary Head and Neck Cancers Sym... Read more
6 Mar 2020
•
17mins
Ranked #14
ICML 2019: Role of Liquid Biopsy in Lymphoma
ICML 2019: Role of Liquid Biopsy in Lymphoma
In this episode, The ASCO Post's Editor-in-Chief Dr. James Armitage talks about the International Conference on Malignan... Read more
3 Jul 2019
•
10mins
Ranked #15
News From the ASTRO Annual Meeting
News From the ASTRO Annual Meeting
This week, we’ll be going over news from the ASTRO Annual Meeting, including an analysis of the effect of long-term horm... Read more
20 Sep 2019
•
20mins
Ranked #16
First-Line Nivolumab and Ipilimumab vs Sunitinib in Advanced Renal Cell Carcinoma
First-Line Nivolumab and Ipilimumab vs Sunitinib in Advanced Renal Cell Carcinoma
This week, we’ll be talking about an extended follow-up of a phase III trial that investigated first-line nivolumab and ... Read more
5 Sep 2019
•
13mins
Ranked #17
Addition of Durvalumab to Etoposide Plus Platinum Chemotherapy for Extensive-Stage SCLC
Addition of Durvalumab to Etoposide Plus Platinum Chemotherapy for Extensive-Stage SCLC
This week, we’ll review an interim analysis of the CASPIAN trial, which evaluated the addition of durvalumab to etoposid... Read more
8 Nov 2019
•
15mins
Ranked #18
Recent Approvals From the FDA
Recent Approvals From the FDA
The FDA certainly had a busy December, and this week, we’ll be reviewing some recent approvals: olaparib for germline BR... Read more
10 Jan 2020
•
16mins
Ranked #19
Reports From the ESMO Asia Congress 2019
Reports From the ESMO Asia Congress 2019
This week, we summarize two studies presented at the recent ESMO Asia Congress—one on a novel combination therapy for un... Read more
27 Nov 2019
•
6mins
Ranked #20
CASSIOPEIA Trial in Multiple Myeloma
CASSIOPEIA Trial in Multiple Myeloma
In this episode, we discuss news from the Annual Congress of the European Hematology Association in multiple myeloma, ca... Read more
27 Jun 2019
•
10mins